Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASPEN AEROGELS INCASPN · Entity 5645 | Director · President and CEO | March 08, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASPEN AEROGELS INC
Report date March 08, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 637,834 |
Reported balance
After 2026-03-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-08 · Tax withholding · Disposed 4,275 · Balance 637,834 F1: 1. Shares withheld by Registrant to satisfy minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F2: Represents 438,349 shares of Common Stock and 199,485 RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: 1. Shares withheld by Registrant to satisfy minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs").
F2: Represents 438,349 shares of Common Stock and 199,485 RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2026 Filed Mar 10, 2026 21:00 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 4,275 | $3.22 | $13,765.50 |
DisclosureSEC source: 0001193125-26-100349 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 637,834 F1 · shares: 1. Shares withheld by Registrant to satisfy minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Represents 438,349 shares of Common Stock and 199,485 RSUs. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 22:00 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 8,618 | $3.27 | $28,180.86 |
DisclosureSEC source: 0001193125-26-096830 · ownership.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 642,109 F2 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F3 · balance_after: Represents 430,387 shares of Common Stock and 211,722 RSUs. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:00 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Options (Right to Buy) · Derivative | 212,249 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0001193125-26-096830 · ownership.xml · derivative · entry 3 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,249 Underlying: Common Stock · 212,249 shares Expires 2036-03-04 F4 · derivative.exercise_date: The options vest as to one-third of the shares on March 4, 2027, an additional one-third of the shares on March 4, 2028 and the remaining one-third of the shares on March 4, 2029. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:00 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 156,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-096830 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650,727 F1 · shares: Each Restricted Stock Unit ("RSU") represents the right to receive one share of Common Stock upon vesting. The RSUs vest as to one-third of the shares on March 4, 2027, an additional one-third of the shares on March 4, 2028 and the remaining one-third of the shares on March 4, 2029. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 22:00 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 56,845 | $3.23 | $183,609.35 |
DisclosureSEC source: 0001193125-25-283251 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 494,011 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a rule 10b5-1 trading plan. This plan was previously adopted by the reporting person on August 11, 2025, to sell a limited number of shares for tax purposes in connection with a one-time personal real estate transaction. F2 · price: These transactions were executed in multiple trades at prices ranging from $3.15 to $3.41. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · balance_after: Represents 414,306 shares of Common Stock and 79,705 Restricted Stock Units. Read SEC document |
| May 12, 2025 Filed May 13, 2025 00:59 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 20,000 | $5.35 | $107,000.00 |
DisclosureSEC source: 0000950170-25-069636 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 550,856 F1 · balance_after: Represents 471,151 shares of Common Stock and 79,705 RSUs. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 22:50 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 3,569 | $7.95 | $28,373.55 |
DisclosureSEC source: 0000950170-25-037450 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 530,856 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Represents 451,151 shares of Common Stock and 79,705 RSUs. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:48 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantPerformance Share Units · Derivative | 108,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-035605 · ownership.xml · derivative · entry 4 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,418 Underlying: Common Stock · 108,418 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share unit ("PSU") represents a contingent right to receive one share of Common Stock upon vesting. The PSUs vest on March 5, 2028, following the completion of the performance period, which begins on January 1, 2025 and ends on December 31, 2027. Ranging between 0-200% of the target number of PSUs (as reflected in Table II above), the PSUs vest based on the total shareholder return of Common Stock relative to the total stockholder return of the components of the Russell 2000 Index. F5 · derivative.exercise_date: Each performance share unit ("PSU") represents a contingent right to receive one share of Common Stock upon vesting. The PSUs vest on March 5, 2028, following the completion of the performance period, which begins on January 1, 2025 and ends on December 31, 2027. Ranging between 0-200% of the target number of PSUs (as reflected in Table II above), the PSUs vest based on the total shareholder return of Common Stock relative to the total stockholder return of the components of the Russell 2000 Index. F5 · derivative.expiration_date: Each performance share unit ("PSU") represents a contingent right to receive one share of Common Stock upon vesting. The PSUs vest on March 5, 2028, following the completion of the performance period, which begins on January 1, 2025 and ends on December 31, 2027. Ranging between 0-200% of the target number of PSUs (as reflected in Table II above), the PSUs vest based on the total shareholder return of Common Stock relative to the total stockholder return of the components of the Russell 2000 Index. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:48 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Options (Right to Buy) · Derivative | 76,417 | $0.00 Strike: $7.84 | $0.00 |
DisclosureSEC source: 0000950170-25-035605 · ownership.xml · derivative · entry 3 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,417 Underlying: Common Stock · 76,417 shares Expires 2035-03-05 F4 · derivative.exercise_date: The options vest as to one-third of the shares on March 5, 2026, an additional one-third of the shares on March 5, 2027 and the remaining one-third of the shares on March 5, 2028. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:48 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 54,209 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-035605 · ownership.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 534,425 F2 · shares: Each Restricted Stock Unit ("RSU") represents the right to receive one share of Common Stock upon vesting. The RSUs vest as to one-third of the shares on March 5, 2026, an additional one-third of the shares on March 5, 2027 and the remaining one-third of the shares on March 5, 2028. F3 · balance_after: Represents 442,484 shares of Common Stock and 91,941 RSUs. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:48 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 2,316 | $7.84 | $18,157.44 |
DisclosureSEC source: 0000950170-25-035605 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,216 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:56 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 1,108 | $8.04 | $8,908.32 |
DisclosureSEC source: 0000950170-25-027210 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,532 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Represents 438,170 shares of Common Stock and 44,362 RSUs. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 15:31 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 63,355 | $30.03 | $1,902,550.65 |
DisclosureSEC source: 0000950170-24-110608 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 483,640 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 Trading Plan previously adopted by the reporting person on June 4, 2024. F2 · price: These transactions were executed in multiple trades at prices ranging from $30.00 to $30.17. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · balance_after: Represents 436,108 shares of Common Stock and 47,532 Restricted Stock Units. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 13:13 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 75,885 | $23.85 | $1,809,857.25 |
DisclosureSEC source: 0000950170-24-079293 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 546,995 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Awards. F2 · balance_after: Represents 499,463 shares of Common Stock and 47,532 Restricted Stock Units. Read SEC document |
| May 29, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionStock Options (Right to Buy) · Derivative | 296,771 | $0.00 Strike: $6.40 | $0.00 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · derivative · entry 11 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 296,771 shares Expires 2025-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. F8 · shares: The reporting person previously disclosed the grant of an aggregate of 454,926 options on December 11, 2015, including 370,181 options subject to performance conditions. Of the performance-based options, 131,578 options were previously forfeited by the reporting person as a result of the applicable performance targets not being achieved. Accordingly, an aggregate of 323,348 options remained exercisable from the December 11, 2015 grant as of the date of this Form 4. F7 · derivative.exercise_date: This option is fully vested and exercisable. F8 · derivative.underlying_shares: The reporting person previously disclosed the grant of an aggregate of 454,926 options on December 11, 2015, including 370,181 options subject to performance conditions. Of the performance-based options, 131,578 options were previously forfeited by the reporting person as a result of the applicable performance targets not being achieved. Accordingly, an aggregate of 323,348 options remained exercisable from the December 11, 2015 grant as of the date of this Form 4. Read SEC document |
| May 29, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 176,746 | $29.38 | $5,192,797.48 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · nonDerivative · entry 7 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 622,880 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. F2 · shares: The shares of common stock were sold solely to satisfy the reporting person's tax withholding obligations related to the exercise of stock options to purchase 691,124 shares as reported herein. F5 · price: These transactions were executed in multiple trades at prices ranging from $28.67 to $29.59. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F6 · balance_after: Represents 418,398 shares of Common Stock and 47,532 Restricted Stock Units and 156,950 shares of Restricted Stock. Read SEC document |
| May 29, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionCommon Stock | 296,771 | $6.40 | $1,899,334.40 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · nonDerivative · entry 6 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 799,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. Read SEC document |
| May 28, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionStock Options (Right to Buy) · Derivative | 26,577 | $0.00 Strike: $6.40 | $0.00 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · derivative · entry 10 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 296,771 Underlying: Common Stock · 26,577 shares Expires 2025-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. F8 · shares: The reporting person previously disclosed the grant of an aggregate of 454,926 options on December 11, 2015, including 370,181 options subject to performance conditions. Of the performance-based options, 131,578 options were previously forfeited by the reporting person as a result of the applicable performance targets not being achieved. Accordingly, an aggregate of 323,348 options remained exercisable from the December 11, 2015 grant as of the date of this Form 4. F7 · derivative.exercise_date: This option is fully vested and exercisable. F8 · derivative.underlying_shares: The reporting person previously disclosed the grant of an aggregate of 454,926 options on December 11, 2015, including 370,181 options subject to performance conditions. Of the performance-based options, 131,578 options were previously forfeited by the reporting person as a result of the applicable performance targets not being achieved. Accordingly, an aggregate of 323,348 options remained exercisable from the December 11, 2015 grant as of the date of this Form 4. Read SEC document |
| May 28, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionStock Options (Right to Buy) · Derivative | 108,105 | $0.00 Strike: $7.54 | $0.00 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · derivative · entry 9 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 108,105 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. F7 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionStock Options (Right to Buy) · Derivative | 259,671 | $0.00 Strike: $10.78 | $0.00 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · derivative · entry 8 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 259,671 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. F7 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 26,286 | $29.72 | $781,219.92 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · nonDerivative · entry 5 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 502,855 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. F2 · shares: The shares of common stock were sold solely to satisfy the reporting person's tax withholding obligations related to the exercise of stock options to purchase 691,124 shares as reported herein. F4 · price: These transactions were executed in multiple trades at prices ranging from $29.59 to $30.00. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 28, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 230,658 | $29.18 | $6,730,600.44 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · nonDerivative · entry 4 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 529,141 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. F2 · shares: The shares of common stock were sold solely to satisfy the reporting person's tax withholding obligations related to the exercise of stock options to purchase 691,124 shares as reported herein. F3 · price: These transactions were executed in multiple trades at prices ranging from $28.59 to $29.58. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 28, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionCommon Stock | 26,577 | $6.40 | $170,092.80 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · nonDerivative · entry 3 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 759,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. Read SEC document |
| May 28, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionCommon Stock | 108,105 | $7.54 | $815,111.70 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 733,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. Read SEC document |
| May 28, 2024 Filed May 30, 2024 00:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Exercise / conversionCommon Stock | 259,671 | $10.78 | $2,799,253.38 |
DisclosureSEC source: 0000950170-24-066183 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 625,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:03 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 4,078 | $17.02 | $69,407.56 |
DisclosureSEC source: 0000950170-24-029213 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,446 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Represents 160,964 shares of Common Stock, 47,532 RSUs and 156,950 shares of Restricted Stock. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:54 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Options (Right to Buy) · Derivative | 87,284 | $0.00 Strike: $16.34 | $0.00 |
DisclosureSEC source: 0000950170-24-028113 · ownership.xml · derivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,284 Underlying: Common Stock · 87,284 shares Expires 2034-03-05 F3 · derivative.exercise_date: The options vest as to one-third of the shares on March 5, 2025, an additional one-third of the shares on March 5, 2026 and the remaining one-third of the shares on March 5, 2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:54 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 19,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-028113 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,524 F1 · shares: Each Restricted Stock Unit ("RSU") represents the right to receive one share of Common Stock upon vesting. The RSUs vest as to one-third of the shares on March 5, 2025, an additional one-third of the shares on March 5, 2026 and the remaining one-third of the shares on March 5, 2027. F2 · balance_after: Represents 152,805 shares of Common Stock, 59,769 RSUs and 156,950 shares of Restricted Stock. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:27 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Disposition to issuerCommon Stock | 304,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-028014 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,635 F1 · shares: Represents unearned performance-based restricted shares granted on June 29, 2021 that were cancelled on March 5, 2024. F2 · balance_after: Represents 152,805 shares of Common Stock, 39,880 RSUs and 156,950 shares of Restricted Stock. Read SEC document |
| February 24, 2024 Filed Feb 27, 2024 18:38 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 818 | $16.96 | $13,873.28 |
DisclosureSEC source: 0000950170-24-020890 · ownership.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 654,786 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Represents 153,290 shares of Common Stock, 39,880 RSUs and 461,616 shares of Restricted Stock. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:38 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 1,099 | $16.96 | $18,639.04 |
DisclosureSEC source: 0000950170-24-020890 · ownership.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 655,604 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 21:41 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (Right-to-Buy) · Derivative | 170,000 | $0.00 Strike: $6.51 | $0.00 |
DisclosureSEC source: 0001209191-23-048828 · doc4.xml · derivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2033-09-07 F1 · derivative.exercise_date: The options will vest in full on September 7, 2026, subject to continuous service through such date. Read SEC document |
| August 08, 2023 Filed Aug 8, 2023 20:13 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 25,000 | $6.83 | $170,697.50 |
DisclosureSEC source: 0001209191-23-044970 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 656,703 F1 · price: The price reported represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.745 to $7.00 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Represents 149,603 shares of Common Stock, 45,484 RSUs and 461,616 shares of Restricted Stock. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:19 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (Right-to-Buy) · Derivative | 168,843 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001209191-23-033702 · doc4.xml · derivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,843 Underlying: Common Stock · 168,843 shares Expires 2033-06-01 F3 · derivative.exercise_date: The options vest as to one-third of the shares on March 8, 2024, an additional one-third of the shares on March 8, 2025 and the remaining one-third of the shares on March 8, 2026. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:19 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 36,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033702 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 631,703 F1 · shares: Each Restricted Stock Unit ("RSU") represents the right to receive one share of Common Stock upon vesting. The RSUs vest as to one-third of the shares on March 8, 2024, an additional one-third of the shares on March 8, 2025 and the remaining one-third of the shares on March 8, 2026. F2 · balance_after: Represents 124,603 shares of Common Stock, 45,484 RSUs and 461,616 shares of Restricted Stock. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 22:14 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 2,210 | $10.95 | $24,199.50 |
DisclosureSEC source: 0001209191-23-013775 · doc4.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,993 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Represents 124,603 shares of Common Stock, 8,774 RSUs and 461,616 shares of Restricted Stock. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 22:14 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 844 | $10.95 | $9,241.80 |
DisclosureSEC source: 0001209191-23-013775 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 597,203 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 23:16 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 1,099 | $11.32 | $12,440.68 |
DisclosureSEC source: 0001209191-23-013366 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598,047 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Represents 117,898 shares of Common Stock, 18,533 RSUs and 461,616 shares of Restricted Stock. Read SEC document |
| May 12, 2022 Filed May 12, 2022 20:37 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 5,000 | $14.63 | $73,150.00 |
DisclosureSEC source: 0001209191-22-028577 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 599,146 F1 · balance_after: Represents 115,827 shares of Common Stock, 21,703 Restricted Stock Units and 461,616 Restricted Stock. Read SEC document |
| February 27, 2022 Filed Mar 2, 2022 00:52 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 11,255 | $29.51 | $332,135.05 |
DisclosureSEC source: 0001209191-22-014398 · doc4.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,146 F3 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of RSUs. F4 · balance_after: Represents 110,827 shares of common stock, 21,703 RSUs and 461,616 restricted shares. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 00:52 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 2,193 | $29.51 | $64,715.43 |
DisclosureSEC source: 0001209191-22-014398 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 605,401 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units("RSUs"). F2 · balance_after: Represents 89,713 shares of Common Stock, 54,072 RSUs and 461,616 restricted shares. Read SEC document |
| February 24, 2022 Filed Feb 26, 2022 00:09 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 737 | $29.00 | $21,373.00 |
DisclosureSEC source: 0001209191-22-013364 · doc4.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 607,594 F3 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units. F4 · balance_after: Represents 84,580 shares of Common Stock, 61,398 RSUs and 461,616 Restricted Stock. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 00:09 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (Right to Buy) · Derivative | 49,795 | $0.00 Strike: $26.29 | $0.00 |
DisclosureSEC source: 0001209191-22-013364 · doc4.xml · derivative · entry 3 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,795 Underlying: Common Stock · 49,795 shares Expires 2032-02-23 F5 · derivative.exercise_date: The options vest as to one-third of the shares on February 23, 2023, and additional one-third of the shares on February 23, 2024 and the remaining one-third of the shares on February 23, 2025. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 00:09 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 9,509 | $26.29 | $249,991.61 |
DisclosureSEC source: 0001209191-22-013364 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,331 F1 · shares: Each Restricted Stock Unit ("RSU") represents the right to receive one share of Common Stock upon vesting. The RSUs vest as to one-third of the shares on February 23, 2023, an additional one-third of the shares on February 23, 2024 and the remaining one-third of the shares on February 23, 2025. F2 · balance_after: Represents 82,882 shares of Common Stock, 63,833 RSUs and 461,616 Restricted Stock. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 01:28 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 17,399 | $51.92 | $903,356.08 |
DisclosureSEC source: 0001209191-21-062858 · doc4.xml · nonDerivative · entry 8 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598,822 F1 · kind: The sales of shares were effected pursuant to a Rule 10b5-1 trading plan of the Reporting Person adopted on August 9, 2021. F16 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $51.51 to $52.40 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F17 · balance_after: Represents 82,882 shares of common stock, 54,324 shares of restricted stock units and 461,616 shares of restricted common stock. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 01:28 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 18,703 | $51.10 | $955,723.30 |
DisclosureSEC source: 0001209191-21-062858 · doc4.xml · nonDerivative · entry 7 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,221 F1 · kind: The sales of shares were effected pursuant to a Rule 10b5-1 trading plan of the Reporting Person adopted on August 9, 2021. F14 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $50.52 to $51.50 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F15 · balance_after: Represents 100,281 shares of common stock, 54,324 shares of restricted stock units and 461,616 shares of restricted common stock. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 01:28 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 4,225 | $51.83 | $218,981.75 |
DisclosureSEC source: 0001209191-21-062858 · doc4.xml · nonDerivative · entry 6 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,924 F1 · kind: The sales of shares were effected pursuant to a Rule 10b5-1 trading plan of the Reporting Person adopted on August 9, 2021. F12 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $51.44 to $51.98 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F13 · balance_after: Represents 118,984 shares of common stock, 54,324 shares of restricted stock units and 461,616 shares of restricted common stock. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 01:28 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 31,878 | $52.43 | $1,671,363.54 |
DisclosureSEC source: 0001209191-21-062858 · doc4.xml · nonDerivative · entry 5 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 639,149 F1 · kind: The sales of shares were effected pursuant to a Rule 10b5-1 trading plan of the Reporting Person adopted on August 9, 2021. F10 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $51.98 to $52.98 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F11 · balance_after: Represents 123,209 shares of common stock, 54,324 shares of restricted stock units and 461,616 shares of restricted common stock. Read SEC document |
| November 01, 2021 Filed Nov 4, 2021 01:28 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 4,702 | $52.17 | $245,303.34 |
DisclosureSEC source: 0001209191-21-062858 · doc4.xml · nonDerivative · entry 4 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,027 F1 · kind: The sales of shares were effected pursuant to a Rule 10b5-1 trading plan of the Reporting Person adopted on August 9, 2021. F8 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $51.73 to $52.53 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F9 · balance_after: Represents 155,087 shares of common stock, 54,324 shares of restricted stock units and 461,616 shares of restricted common stock. Read SEC document |
| November 01, 2021 Filed Nov 4, 2021 01:28 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 22,241 | $53.05 | $1,179,885.05 |
DisclosureSEC source: 0001209191-21-062858 · doc4.xml · nonDerivative · entry 3 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,729 F1 · kind: The sales of shares were effected pursuant to a Rule 10b5-1 trading plan of the Reporting Person adopted on August 9, 2021. F6 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $52.54 to $53.54 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F7 · balance_after: Represents 159,789 shares of common stock, 54,324 shares of restricted stock units and 461,616 shares of restricted common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.